Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

AI-powered algorithm can analyze video recordings of clinical sleep tests and more accurately diagnose REM sleep behavior disorder.

Apple this month received approval to launch the Apple Watch's sleep apnea notifications feature in Malaysia, as noted by ...

Medicare drug plans can now cover Eli Lilly & Co.'s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that's expected to prove a big boost for the drug company.

Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Poor sleep hygiene can lead to negative health outcomes, but what exactly is sleep hygiene and how can you improve it?

Patients with metabolic dysfunction–associated steatotic liver disease experience poor sleep due to sleep fragmentation and ...

WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug to get the green light to ...